Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1176 of 5804
-
New drug HRS-9813 aims to slow lung scarring in fibrosis patients
Disease control Recruiting nowTo evaluate the efficacy and safety of HRS-9813 in subjects with pulmonary fibrosis。
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New drug combo aims to tame acromegaly hormone levels
Disease control Recruiting nowThe primary objective of this study is to evaluate the efficacy of 15-week treatment with ALXN2420 versus placebo for decreasing insulin-like growth factor IGF-1 levels, when administered in combination with somatostatin analog (SSA) therapy to adult participants with acromegaly.
Phase: PHASE2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New drug trial aims to improve survival in ARDS patients
Disease control Recruiting nowThis is a Phase 2 multicenter, randomized, double-blinded, placebo-controlled study that will evaluate the safety and efficacy of host-directed therapeutics in hospitalized adults diagnosed with Acute Respiratory Distress Syndrome (ARDS) utilizing a platform trial design. Cohort…
Phase: PHASE2 • Sponsor: PPD Development, LP • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Tailored radiation: new trial aims to personalize cancer treatment
Disease control Recruiting nowTo characterize feasibility, safety, and/or preliminary efficacy of personalized strategies to adapt standard radiotherapy treatments to individual patient responses.
Phase: PHASE1 • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New pill aims to tame irregular heartbeat in atrial fibrillation patients
Disease control Recruiting nowA randomized, placebo-controlled, participant-and investigator-blinded study to evaluate the efficacy in reducing atrial fibrillation burden as well as the safety, tolerability and pharmacokinetics of PKN605 in participants with atrial fibrillation
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New study brings genetic testing to newborns in underserved texas hospitals
Diagnosis Recruiting nowThe purpose of this study is to provide advanced genetic testing and virtual consultations for seriously ill newborns in hospitals in Texas with fewer resources, especially along the Texas-Mexico border. The researchers also want to know how well the virtual consultation tool, ca…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Peer power: can friends help stop HIV in injection drug users?
Prevention Recruiting nowThe goal of this clinical trial is to evaluate the effectiveness of a social network intervention to recruit people who inject drugs and their networks for HIV testing and linkage to HIV prevention and treatment services in Maryland. Study aims are to determine the effectiveness …
Phase: NA • Sponsor: Johns Hopkins University • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
New blood test could predict heart transplant complications before they happen
Knowledge-focused Recruiting nowThis study aims to develop and refine a microRNA (miR) biomarker panel that can be used to phenotype net immune state after heart transplantation using circulating miRs (associated with drug doses and levels). These miRs will be used to characterize the overall immune state in ad…
Sponsor: Inova Health Care Services • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Can a probiotic help knock out Hard-to-Treat stomach bugs?
Disease control Recruiting nowThis study aims at evaluating efficacy and safety of Saccharomyces boulardii combined with bismuth-containing quadruple Therapy versus bismuth-containing quadruple Therapy(bismuth#esomeprazole#tetracycline and furazolidone) in H. pylori rescue therapy. It is hypothesized that Sac…
Phase: PHASE4 • Sponsor: Yongquan Shi • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
New hope for pancreatic cancer: targeted drug combo enters human testing
Disease control Recruiting nowThis is a Phase 1b dose escalation trial of OMTX705, an anti-fibroblast activation protein (FAP) antibody-drug conjugate (ADC), in combination with gemcitabine/nab-paclitaxel and tislelizumab in patients with advanced/metastatic pancreatic ductal adenocarcinoma (PDAC). The trial…
Phase: PHASE1 • Sponsor: Oncomatryx Biopharma S.L. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can friends and family become overdose heroes? chicago study aims to find out
Knowledge-focused Recruiting nowFatal opioid overdoses are more frequent among populations with low access to harm reduction (HR) services and with high substance use-related stigma (which is a major barrier to accessing HR services). One such population is older adults who use drugs (PWUD) on the West side of …
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC
-
Rio study tests antibiotic after sex to stop STIs
Prevention Recruiting nowThe goal of this clinical trial is to learn if doxycycline post-exposure prophylaxis (doxy-PEP) can help prevent bacterial sexually transmitted infections (STIs) among sexual and gender minorities in Rio de Janeiro, Brazil, including men who have sex with men, transgender women, …
Phase: NA • Sponsor: Oswaldo Cruz Foundation • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New epilepsy drug vormatrigine tested for Long-Term safety in 700 adults
Disease control ENROLLING_BY_INVITATIONOpen Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy
Phase: PHASE3 • Sponsor: Praxis Precision Medicines • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New blood test aims to detect hidden infections in vulnerable patients
Diagnosis Recruiting nowThis clinical trial is designed to evaluate if adding the Karius Spectrum™ plasma test to usual care diagnostic tests, compared to usual care testing alone, among immunocompromised participants presenting with suspected infection in the outpatient setting leads to faster infectio…
Phase: NA • Sponsor: Karius, Inc. • Aim: Diagnosis
Last updated Jun 27, 2026 09:00 UTC
-
Radioactive drug targets brain tumors in early trial
Disease control Recruiting nowThe researchers are doing this study to find out whether the radiopharmaceutical therapy (RPT) 177Lu-PSMA-617 is a safe treatment for people with IDH wild type glioma.
Phase: PHASE1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Wellness devices show promise for long COVID relief
Symptom relief CompletedThe purpose of this study is to explore whether two general wellness products, alone or combined, can support individuals experiencing Long COVID symptoms. Both wellness products stimulate the vagus nerve - a nerve that helps regulate stress, relaxation, mood, breathing, heart ra…
Phase: NA • Sponsor: Leidos Life Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 08:08 UTC
-
New combo targets tough colorectal cancer in Liver-Free patients
Disease control Recruiting nowThis is a prospective, randomized, open-label, multicenter phase II investigating the therapy of Fruquintinib in combination with Tislelizumab in patients with MSS/pMMR metastatic colorectal cancer without liver metastases.
Phase: PHASE2 • Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Supercharged donor cells take on lymphoma in early trial
Disease control Recruiting nowThis study involves patients with diffuse large B cell lymphoma (DLBCL), natural killer/T-cell lymphoma (NKTL), or classical Hodgkin lymphoma (cHL) (referred to collectively as lymphoma) whose disease has returned or not responded to treatment. Previous research combined antibod…
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can a second round of radiation save breasts after cancer returns?
Disease control Recruiting nowThe purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surg…
Phase: NA • Sponsor: Youssef Zeidan • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New MRI techniques aim to spy on brain Tumor's immune defenses
Knowledge-focused Recruiting nowThis phase III trial is evaluating whether a combination of three advanced magnetic resonance imaging (MRI) techniques, including chemical exchange saturation transfer (CEST) MRI, diffusion-relaxation correlation spectrum imaging (DR-CSI), and ferumoxytol-enhanced magnetic resona…
Phase: PHASE3 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC